Research programme: hetero aromatic polycycle antibacterials - Oscient
Alternative Names: GSQ 10547; GSQ 11203; GSQ 2287; GSQ 5028; GSQ 7302; HARP antibacterials research programme - Oscient; Hetero aromatic polycycle antibacterials research programme - OscientLatest Information Update: 24 Nov 2004
At a glance
- Originator Oscient Pharmaceuticals
- Class Small molecules
- Mechanism of Action DNA inhibitors; RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 24 Nov 2004 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 13 Apr 2004 Genome Therapeutics is now called Oscient Pharmaceuticals
- 12 Feb 2004 GeneSoft has merged with Genome Therapeutics